FNWFX
Price
$81.52
Change
+$0.18 (+0.22%)
Updated
May 8 closing price
Net Assets
63.55B
PRIAX
Price
$27.90
Change
+$0.09 (+0.32%)
Updated
May 8 closing price
Net Assets
2.61B
Ad is loading...

FNWFX vs PRIAX

Header iconFNWFX vs PRIAX Comparison
Open Charts FNWFX vs PRIAXBanner chart's image
American Funds New World F3
Price$81.52
Change+$0.18 (+0.22%)
VolumeN/A
Net Assets63.55B
Principal Glb Emerging Markets A
Price$27.90
Change+$0.09 (+0.32%)
VolumeN/A
Net Assets2.61B
FNWFX vs PRIAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FNWFX vs. PRIAX commentary
May 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FNWFX is a Buy and PRIAX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
FNWFX has more cash in the bank: 63.6B vs. PRIAX (2.61B). FNWFX pays higher dividends than PRIAX: FNWFX (1.21) vs PRIAX (0.00). FNWFX was incepted earlier than PRIAX: FNWFX (8 years) vs PRIAX (20 years). PRIAX (1.56) is less costly to investors than FNWFX (0.57). FNWFX is a more actively managed with annual turnover of: 37.00 vs. PRIAX (28.50). PRIAX has a lower initial minimum investment than FNWFX: PRIAX (1000) vs FNWFX (1000000). PRIAX annual gain was more profitable for investors over the last year : 6.83 vs. FNWFX (3.55). FNWFX return over 5 years is better than : 38.31 vs. PRIAX (32.45).
FNWFXPRIAXFNWFX / PRIAX
Total Expense Ratio0.571.4739%
Annual Report Gross Expense Ratio0.571.5637%
Fund Existence8 years20 years-
Gain YTD5.8436.99284%
Front LoadN/A6%-
Min. Initial Investment10000001000100,000%
Min. Initial Investment IRAN/AN/A-
Net Assets63.6B2.61B2,441%
Annual Yield % from dividends1.210.00-
Returns for 1 year3.556.8352%
Returns for 3 years27.4520.45134%
Returns for 5 years38.3132.45118%
Returns for 10 yearsN/A18.52-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SBHIX22.55N/A
N/A
Saratoga Health & Biotechnology I
GCVTX22.40N/A
N/A
Goldman Sachs Large Cp Val Insghts Inv
SVBAX28.19N/A
N/A
JHancock Balanced A
IFPUX20.03N/A
N/A
Independent Franchise Partners US Equity
ARRBX13.25N/A
N/A
Aristotle Small Cap Equity R6